NCHR Testimony at FDA About New Opioid Combination, Hydexor

February 14, 2018. Consider how this drug fits into the context of the drug market and how it is likely to be used or misused. Do the benefits outweigh the risks of putting another conventional opioid on the market, one that is designed to treat its own side effects, and are the attempts to reduce excess pills sufficient? Opioids provide both a benefit and a harm in our society. As Advisory Board members, please advise the FDA to carefully and cautiously consider the potential for abuse of this opioid.

Read More »

Testimony of Dr. Diana Zuckerman before the Maryland House of Delegates Appropriations Committee on the Health Risks of Artificial Turf

February 8, 2018. It is essential that the State of Maryland stop paying for artificial turf fields and playgrounds that can clearly exacerbate our children’s existing health problems and cause new  health problems. Let’s instead invest in safe, natural playing fields, unless any artificial alternatives are proven to be safer, more effective, and as cost-effective as grass.

Read More »

NCHR Testimony to House Appropriations Committee Regarding Playground and Athletic Field Surfaces

February 8, 2018. Companies that make and install synthetic turf on these types of surfaces maintain that it is proven safe and cost-effective compared to grass.  However, these materials are not required by any federal government agency to be proven safe. These surfaces can expose children to harmful chemicals and can put children at risk of injury. We appreciate the Committee’s close attention and legislative oversight of this important safety issue for our state’s children and their schools.

Read More »